BRIMROSE TECHNOLOGY CORP — Department of Defense SBIR Phase II: DHA SBIR PHASE II ROBUST, SPECKLE-TOLERANT HANDHELD NON-CONTACT VITAL SIGN MONITOR WITH PH
BRIMROSE TECHNOLOGY CORP — SBIR Phase II award from Department of Defense.
Phase II SBIR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $1,299,807 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Tagged technology areas: Sensors & Sensor Fusion, Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Brimrose Technology Corp received over $1.3 million to develop a handheld, non-contact vital sign monitor using photonics integrated circuits. The device is designed to be robust and tolerant to speckle interference for military health applications.
- Amount
- $1,299,807
- Agency
- Department of Defense · Defense Health Agency
- Program / Phase
- SBIR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- MD
- Period
- 2024-08-28 → 2026-12-27
Technology domains
Description
DHA SBIR PHASE II ROBUST, SPECKLE-TOLERANT HANDHELD NON-CONTACT VITAL SIGN MONITOR WITH PHOTONICS INTEGRATED CIRCUITS